IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Efficacy and safety of nifedipine GITS in Asians with hypertension - Results of a post-marketing surveillance study in China
Gao Runlin; Zhu Junren; Liu Guozhang; Zhang Weizhong; Zhang Tingjie; Sun Ningling; Landen, Harald
刊名CLINICAL DRUG INVESTIGATION
2007
27期:8页:565-572
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]TO-MODERATE HYPERTENSION ; CALCIUM-CHANNEL BLOCKER ; BLOOD-PRESSURE ; MANAGEMENT ; PROGRESSION ; GUIDELINES ; MORBIDITY ; MORTALITY ; RELEASE ; SOCIETY
英文摘要

Objective: This post-marketing surveillance study assessed the efficacy, safety and tolerability of treatment with nifedipine GITS (gastrointestinal therapeutic system) in hypertensive patients with different risk profiles under normal daily practice conditions in China.

Methods: A total of 7395 patients were included in 564 outpatient clinics. Patients received 30mg or 60mg of nifedipine GITS, which could be up- and down-titrated if necessary. Efficacy, safety and tolerability data were collected at up to three follow-up visits. Patient documentation was completed using standardised and barcoded case report forms. Descriptive and explorative analyses of the data were performed.

Results: At endpoint, 93% of patients were receiving 30mg of nifedipine GITS and 7% were taking 60mg of nifedipine GITS. The mean observation period was 9 +/- 7 weeks. At endpoint, the mean BP reduction was 27.7/14.8mm Hg; 43% of patients had a systolic BP < 140mm Hg, and 58% had a diastolic BP < 90mm Hg. BP control as recommended by international guidelines was achieved in 43.5% of all patients. A total of 3163 patients (42.8%) received additional anti hypertensive medication, of which ACE inhibitors were most commonly used (40.7%), followed by P-adrenoceptor antagonists (25.8%).

Twenty-nine patients (0.4%) experienced a total of 39 adverse events. Subjective physicians′ assessments of efficacy, tolerability and patient acceptance of nifedipine GITS treatment returned ratings of ′very good′ and ′good′ in 91-95% of each category.

Conclusions: Nifedipine GITS proved to be effective and well tolerated for the treatment of hypertension in 7395 Chinese patients under normal daily practice conditions. The results confirm the findings and experience of previously performed clinical studies.

语种英语
WOS记录号WOS:000248531500006
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57339
专题北京大学第二临床医学院
作者单位1.Zhongshan Hosp, Shanghai, Peoples R China
2.Ruijin Hosp, Shanghai Inst Hypertens, Shanghai, Peoples R China
3.Chengdu First Municipal Hosp, Chengdu, Peoples R China
4.Beijing Univ, Peoples Hosp, Beijing 100871, Peoples R China
5.Bayer Vital GmbH, Bayer HealthCare, PMS Management, D-51368 Leverkusen, Germany
6.Fuwai Cardiovasc Inst & Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Gao Runlin,Zhu Junren,Liu Guozhang,et al. Efficacy and safety of nifedipine GITS in Asians with hypertension - Results of a post-marketing surveillance study in China[J]. CLINICAL DRUG INVESTIGATION,2007,27(8):565-572.
APA Gao Runlin.,Zhu Junren.,Liu Guozhang.,Zhang Weizhong.,Zhang Tingjie.,...&Landen, Harald.(2007).Efficacy and safety of nifedipine GITS in Asians with hypertension - Results of a post-marketing surveillance study in China.CLINICAL DRUG INVESTIGATION,27(8),565-572.
MLA Gao Runlin,et al."Efficacy and safety of nifedipine GITS in Asians with hypertension - Results of a post-marketing surveillance study in China".CLINICAL DRUG INVESTIGATION 27.8(2007):565-572.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Gao Runlin]的文章
[Zhu Junren]的文章
[Liu Guozhang]的文章
百度学术
百度学术中相似的文章
[Gao Runlin]的文章
[Zhu Junren]的文章
[Liu Guozhang]的文章
必应学术
必应学术中相似的文章
[Gao Runlin]的文章
[Zhu Junren]的文章
[Liu Guozhang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。